SCOTTSDALE, Ariz., July 18, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its second quarter 2024 earnings release before the market opens on Thursday, August 8, 2024. LifeStance will host a live earnings conference call to discuss second quarter results on August 8, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationall ...

TORONTO, July 18, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, reports that its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. ("Mikra") has unveiled its Big Summer Sale, with a free gift included with every order while supplies last. The sale is on now, and customers are invited to ...

The mean estimate comprises seven short-term price targets with a standard deviation of $0.94. While the lowest estimate of $7 indicates a 27.5% increase from the current price level, the most optimistic analyst expects the stock to surge 82.2% to reach $10. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts. However, an impressive consensus price target is not the only ...

CELLF 2.0 provides a complete adult daily dose of Pyrroloquinoline Quinone (PQQ) and Glutathione, alongside the recommended dose of bioavailable CoQ10, in a liposomal gel that is precision engineered to protect all of these key molecules from the corrosive effects of stomach acid, delivering them safely to be absorbed by the small intestine and guaranteeing that the full clinical dose becomes bioavailable. The latest published research confirms the vital role played by CELLF 2.0's key ingredients. In 2023 a ...

SSC is a leading Canadian cannabis company which has successfully implemented innovative systems and operational methodologies resulting in six straight quarters of positive EBITDA and positive net income in Q1 2024. Lifeist shareholders are set to immediately benefit by having SSC support the operations of CannMart, deploying SSC's expertise from its existing operations, while enjoying a fee structure which ensures a minimum net revenue amount to be retained by CannMart each month. This arrangement will al ...

We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30. Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and e ...

SCOTTSDALE, Ariz., May 23, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will participate in the following upcoming investor conferences. UBS Healthcare Services Cape Cod Summit Participants: Dave Bourdon, CFO, and Monica Prokocki, VP of Finance and Investor Relations Date: Tuesday, June 4, 2024 Location: Chatham Bars Inn, Chatham, MA Note: No presentation due to event format; inv ...

SCOTTSDALE, Ariz., May 23, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will participate in the following upcoming investor conferences. UBS Healthcare Services Cape Cod Summit Participants: Dave Bourdon, CFO, and Monica Prokocki, VP of Finance and Investor Relations Date: Tuesday, June 4, 2024 Location: Chatham Bars Inn, Chatham, MA Note: No presentation due to event format; inv ...

LifeStance Health (NASDAQ:LFST) stock is down on Wednesday after the mental health services company announced the pricing of a secondary offering for its shares. LifeStance Health says that a group of stockholders are selling shares of LFST stock in this public offering. This has them pricing the company's shares at $6.25 each. They will sell a total of 20 million shares in the offering. In addition to this, the underwriters of the offering have a 30-day option to acquire another 3 million shares at this of ...

SCOTTSDALE, Ariz., May 21, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (Nasdaq: LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 20,000,000 shares of LifeStance's common stock, par value $0.01 per share (the "Common Stock") at a public offering price of $6.25 per share, pursuant to a shelf registration statement filed with the Securities an ...